Skip to main content
. Author manuscript; available in PMC: 2011 Mar 8.
Published in final edited form as: J Psychopharmacol. 2008 Jul 1;22(6):621–632. doi: 10.1177/0269881108094300

Table 1.

Volunteer Ratings on the Pahnke-Richards Mystical Experience Questionnaire section of the State of Consciousness Questionnaire completed at the end of methylphenidate and psilocybin sessions, and again retrospectively for psilocybin at the 14-month follow-up a

Scale Description Methylphenidate
(post-session)b
(N=36)
Psilocybin
(post-session)
(N=36)
Psilocybin
(14 months)
(N=36)
Internal unity 0.26 (0.04) 0.73 (0.05)* 0.71 (0.05)*
External unity 0.22 (0.04) 0.64 (0.05)* 0.67 (0.05)*
Sacredness 0.38 (0.04) 0.80 (0.04)* 0.78 (0.04)*
Intuitive knowledge 0.32 (0.05) 0.74 (0.05)* 0.73 (0.04)*
Transcendence of time and space 0.27 (0.04) 0.75 (0.04)* 0.75 (0.04)*
Deeply felt positive mood 0.39 (0.04) 0.75 (0.04)* 0.70 (0.05)*
Ineffability and paradoxicality 0.33 (0.04) 0.80 (0.04)* 0.78 (0.05)*
Mean total score 0.33 (0.04) 0.76 (0.04)* 0.75 (0.04)*
a

Data are mean scores with 1 S.E.M. shown in parentheses; data are expressed as a proportion of the maximum possible score

b

For the 6 subjects who received methylphenidate on two sessions, the data are from the first session

*

Indicates significant difference from the post-methylphenidate condition (p<.05); there were no significant differences between the psilocybin post-session condition and the psilocybin 14-month follow-up